ClinicalTrials.gov
public full text
Public Domain
Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression
This study will determine the effectiveness of desipramine in improving cellular signaling, and thereby decreasing symptoms of depression in people with major depressive disorder (MDD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- New Approaches to Cocaine Abuse Medications (A) - 6#801814
- Pharmacotherapy and Intensive Treatment of Drug Abuse - 1#852289
- Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial#890995
- Switching to Duloxetine in Patients With Depression#968126
- Duloxetine for Perimenopausal Depression#897078
Record · ID 916997
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive